Phase 1 ACCEL trial recruiting: AC-22... - Fight Prostate Ca...

Fight Prostate Cancer

2,993 members1,375 posts

Phase 1 ACCEL trial recruiting: AC-225-PSMA-62 for OLIGOMETASTATIC HSPC and mCRPC

Maxone73 profile image
10 Replies

I am not oligometastatic, dammit! But this could really be something worth trying! It is, at least from preclinical studies, a more targeted version of the previous Actinium based therapies.

The ACCEL trial is a Phase 1 clinical study testing Actinium-225-labeled PSMA-62, a targeted radioligand therapy for oligometastatic hormone-sensitive prostate cancer and metastatic castration resistant prostate cancer.

This therapy combines Actinium-225, a powerful alpha-emitting radioisotope, with PSMA-62, a molecule that binds to Prostate-Specific Membrane Antigen (PSMA) on cancer cells.

By delivering precise radiation, it aims to destroy cancer cells while sparing healthy tissue. Early results show strong anti-tumor effects with manageable side effects.

prostatewarriors.com/2025/0...

Written by
Maxone73 profile image
Maxone73
To view profiles and participate in discussions please or .
Read more about...
10 Replies
Fonske profile image
Fonske

Recruiting only in Canada.

When in Europe?

Maxone73 profile image
Maxone73 in reply toFonske

I wish I knew the answer! But you never know!

Fonske profile image
Fonske in reply toMaxone73

Please, do not get me wrong because I love beaucoup nos amis canadiens 😍

I even have relatives in Quebec 😍

Maxone73 profile image
Maxone73 in reply toFonske

Don't worry, soon Canada will become the 21st region of Italy, so it will all be closer to Belgium

Petertanner profile image
Petertanner

Current trial with Actinium 225-PSMA-TRILLIUM ongoing at Royal Marsden in the UK.

GreenStreet profile image
GreenStreet in reply toPetertanner

thanks for the info 👍

Islandboy2021 profile image
Islandboy2021

Thanks for posting this trial. I am talking to the trial doctors in Vancouver about this trial. I have missed a few trials in the last year and a half. Its not easy to get into these as they fill up quickly. I did notice they are going to have the same trial in Hamilton Ontario. If I don't get into the Vancouver trial I will try Hamilton. My Father lives nearby there and I only would have to cover my flights.

I did have one concern with the eligibility criteria . I have had chemo therapy a number of times. I handled the treatments fine when using Grastofil. It mentions only having chemo once.

I am at the point of no return. If I don't get treatment soon I will be in hospice care within a few weeks. The tumors are starting to effect my bone marrow and I am having pain everywhere.

Maxone73 profile image
Maxone73 in reply toIslandboy2021

Some trials can extend their reach by something called compassionate use, your MO surely knows about it. I do not see anything that would disqualify you for the trial anyway. Is Canada your only option?

Islandboy2021 profile image
Islandboy2021

The compassionate use is a great option. I will make sure that we ask for that. Canada is the best option for me. I am not wealthy and have a family with one daughter still at home. I have been working since diagnosis in 2017. I feel now that I will have to step away from work soon. I have been lucky with work as I have been able to work from home some and make my own schedules.

Thanks for all your posts, it really helps to figure out the next steps.

Maxone73 profile image
Maxone73 in reply toIslandboy2021

Have your MO check also the following:

clinicaltrials.gov/study/NC...

clinicaltrials.gov/study/NC...

clinicaltrials.gov/study/NC...

clinicaltrials.gov/study/NC...

clinicaltrials.gov/study/NC...

You will have to consider various factors as every treatment has its limitations

Not what you're looking for?

You may also like...

Phase 3 trial: 177Lu-DOTA-rosopatamab (TLX591) for patients with PSMA expressing metastatic castration-resistant prostate cancer

Doctors in Perth, Australia are leading a Phase 3 clinical trial called ProstACT GLOBAL, which is...
Maxone73 profile image

Phase 1 recruiting: QXL138AM, for CD138 expressing tumors

Another one I almost missed... CD138 is expressed in advanced and aggressive prostate cancers,...
Maxone73 profile image

Phase 2 trial will start soon: opaganib plus darolutamide for mCRPC

A phase 2 clinical trial will start to assess the combination of opaganib (ABC294640) and...
Maxone73 profile image

Oligometastatic prostate cancer: Reality or figment of imagination?

New paper below, [1] full text. Oligometastatic PCa has been controversial from the start, with...
pjoshea13 profile image

Metastasis Directed Therapy (MDT) is here to stay for Oligometastatic Patients !!! Part(1) SABR/SBRT

Greetings FPC Members, Metastasis Directed Therapy (MDT) is becoming a standard of treatment in...
NPfisherman profile image